What should breast cancer patients know about radiotherapy treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Key Information Breast Cancer Patients Should Know About Radiotherapy

Postoperative radiotherapy is strongly recommended after breast-conserving surgery as it reduces the risk of local recurrence by two-thirds and has a beneficial effect on survival. 1

Purpose and Benefits of Radiotherapy

  • Radiotherapy significantly reduces the risk of local breast cancer recurrence after surgery
  • For breast-conserving surgery (BCS), radiotherapy:
    • Reduces local recurrence risk by approximately 66%
    • Provides survival benefits 1
    • Is considered standard treatment for all patients regardless of disease characteristics 2
  • For mastectomy, radiotherapy is recommended for:
    • Patients with 4 or more positive axillary lymph nodes (category 1 recommendation) 1
    • Patients with T3-T4 tumors regardless of nodal status 1
    • Patients with 1-3 positive nodes with additional risk factors (young age, vessel invasion) 1

Standard Radiotherapy Protocol

  • Timing: Usually begins 2-4 weeks after uncomplicated surgery 1
  • Standard whole breast dose: 45-50 Gy delivered in 25-28 fractions of 1.8-2.0 Gy 1
  • Alternative hypofractionation schedules:
    • 42.5 Gy in 16 fractions
    • 40 Gy in 15 fractions 2
  • Boost dose: An additional 10-16 Gy to the tumor bed is recommended for:
    • Patients under 50 years of age 1, 3
    • Those with high risk of recurrence 1
  • Treatment schedule: Daily treatments, Monday through Friday 1

Side Effects and Complications

Patients should be aware of potential side effects:

  • Short-term effects:

    • Skin reactions (redness, irritation)
    • Fatigue
    • Breast swelling or tenderness
  • Long-term effects:

    • Breast firmness or shrinkage
    • Skin changes
    • Potential cardiac toxicity (particularly for left-sided breast cancers) 1
    • Radiation pneumonitis (inflammation of lung tissue) 1

Follow-up Care After Radiotherapy

  • Regular follow-up schedule:

    • Every six months for years 1-5
    • Annually thereafter 1
  • Mammography schedule:

    • Baseline mammogram within 6-12 months after completing treatment
    • Annual mammograms thereafter 1

Special Considerations

  • Pregnancy is a contraindication to radiotherapy 4
  • Previous breast irradiation (including for Hodgkin's disease) contraindicates further radiotherapy 4
  • Patients with scleroderma or systemic lupus erythematosus require special consideration 4
  • For left-sided breast cancers, special techniques may be used to minimize heart exposure 1
  • Radiation therapy techniques should avoid excess dose to heart and lungs 1

Breast Reconstruction Considerations

  • Breast reconstruction is an option for women receiving surgical treatment for breast cancer 1
  • The decision regarding type of reconstruction depends on:
    • Patient preference
    • Body habitus
    • Smoking history (increases complication risk)
    • Comorbidities
    • Plans for irradiation 1
  • Radiation timing may need to be coordinated with reconstruction plans
  • Patients should consult with a reconstructive surgeon before making decisions 1

Emerging Approaches

  • Partial breast irradiation may be suitable for selected patients:
    • Women at least 50 years old
    • Unicentric, unifocal node-negative non-lobular breast cancer up to 3 cm
    • No extensive intraductal component or lymphovascular invasion
    • Negative margins of at least 2 mm 1

Understanding these aspects of radiotherapy can help breast cancer patients make informed decisions about their treatment and know what to expect during and after the radiotherapy process.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Radiotherapy of breast cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.